ロード中...
Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation
BACKGROUND: Previous models of Hospital at Home (HAH) for COPD exacerbation (ECOPD) were limited by the lack of a reliable prognostic score to guide patient selection. Approximately 50% of hospitalised patients have a low mortality risk by DECAF, thus are potentially suitable. METHODS: In a non-infe...
保存先:
| 出版年: | Thorax |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6204956/ https://ncbi.nlm.nih.gov/pubmed/29680821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2017-211197 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|